Mike Liao

Company: Third Arc Bio

Job title: Vice President, Clinical Pharmacology

Seminars:

Panel Discussion: Reflections From Drug Developers: What Worked When Applying MIDD, What Didn’t & Why? 1:00 pm

Hear firsthand experiences on how MIDD strategies have successfully expedited clinical and regulatory milestones Explore common challenges and resistance factors that limited MIDD adoption, with advice on overcoming these obstacles Analyze retrospective case studies to identify best practices and lessons learned from embedding MIDD more effectively across development teamsRead more

day: Day 2

Accelerating Clinical Trial Entry: Tailoring Modality-Specific- MIDD Strategies for Maximum Efficiency in ADC & TCE trials 11:30 am

Hear advice on designing modality-specific approaches where strategic plans were uniquely differed for contrasting modalities Learn the type of in vitro and in vivo data required for translational modeling for FIH dose selection for ADCs and TCEs Gain insights from case studies where this tailoring approach has enabled acceleration of clinical trialsRead more

day: Day 1